Singhvi Rahul 4
4 · Kairos Pharma, LTD. · Filed Nov 26, 2025
Insider Transaction Report
Form 4
Singhvi Rahul
Director
Transactions
- Award
COMMON STOCK
2025-10-08+19,084→ 49,204 total
Footnotes (2)
- [F1]Represents 19,084 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 19,084 RSUs are scheduled to vest in full on the first anniversary of the grant date.
- [F2]Consists of 49,204 RSUs which remain subject to vesting.